Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,307
Out of 4,667 analysts
4
Total ratings
n/a
Success rate
-50.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $3.29 | +14,489.67% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $15,000 | $0.12 | +12,135,822.33% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $13.55 | +16,505.17% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $19.00 | +1,005.26% | 1 | Feb 19, 2020 |
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $3.29
Upside: +14,489.67%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $15,000
Current: $0.12
Upside: +12,135,822.33%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $13.55
Upside: +16,505.17%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $19.00
Upside: +1,005.26%